• Latest Posts
More News! 6 Feb 2019

British Biotech Spin-Offs Get €40M Funding to Treat Narcolepsy

British Biotech Founder Receives the Nobel Prize in Chemistry 2017

Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal

Interview 17 Jul 2017

Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares

Heptares receives €4.5M Milestone for New Migraine Drug Candidate

Heptares Finds New GPCR Target to Treat Pain, Cancer and Inflammation


Heptares Takes Home €11M for its Next-Generation Checkpoint Inhibitor

What are the Best Countries to Recruit Biotech Talents in 2017?

New British Biotech-Academia Alliance takes on Cardiovascular Disease

The Largest Deals, Fundraising and Exits of 2016 in European Biotech

Drugging the Undruggable: New Acquisition to Boost GPCR Drugs

These Biotech Veterans have Launched a Startup to ‘Drug the Undruggable’